http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
reducing the risk for coronary heart disease
Pt. 1. Fundamentals of lipid metabolism -- Plasma lipoproteins: structure, nomenclature, and occurrence -- Intracellular lipid synthesis and lipoprotein assembly -- Remodeling of lipoproteins in the plasma compartment -- Lipoprotein catabolism -- Pt. 2. Atherosclerosis -- Atherosclerosis: overview and histologic classification of lesions -- Evolution of lesions -- Atherosclerosis and myocardial infarction: a sea change in concept -- Mechanisms of atherosclerosis beyond low-density lipoprotein -- Other hypotheses, allograft coronary heart disease, and restenosis -- Lesion regression and stabilization -- Pt. 3. Risk control -- Observational epidemiology and risk factors -- Major lipid-lowering trials assessing clinical events -- National Cholesterol Education Program algorithm for risk control in adults -- Considerations in the clinical evaluation of dyslipidemia -- Pt. 4. Therapeutic interventions -- Dietary modification -- Other lifestyle changes and major modifiable risk factors -- Lipid-regulating drugs and low-density lipoprotein apheresis -- Pt. 5. Plasma lipid control and coronary heart disease risk considerations in population subsets -- Women -- The elderly and youths -- U.S. ethnic minorities -- Adults with diabetes mellitus and patients with concomitant dyslipidemia and hypertension -- Chart 1: Lipid conversions, with NCEP intial clinical action limits in adults -- Chart 2: Cutpoints in adult clinical practice guidelines.
Antonio M. Gotto, Jr., Henry J. Pownall.
Includes bibliographical references and index.